from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3769/-

LFCtreatmentdescriptionclass of inhibitor

-0.308

Amikacinug/mL Amikacintranslation

1.073

Cap5-10ug/mL Capreomycintranslation

1.148

Rox10-50 ug/mL Roxithromycintranslation

0.692

SM2-5 ug/mL Streptomycintranslation

1.598

Tet5-10 ug/mL Tetracyclinetranslation

-0.049

Rif0.2-5ug/mL Rifampicintranscription

0.288

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.561

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.087

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.978

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.042

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.199

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.146

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.410

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.202

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.073

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.467

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.154

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.070

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.182

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.931

KCN5-20 ug/mL Potassium cyaniderespiration

0.297

NaN30.2-2 mM Sodium aziderespiration

0.581

Nigericin50 uM Nigericinrespiration

-0.887

TRC10-150 ug/mL Triclosanrespiration

-1.602

TRZ10-25 ug/mL Thioridazinerespiration

0.298

Valinomycin0.5-10 uM Valinomycinrespiration

0.489

ZnSO42 mM ZnSO4respiration

0.238

menadione6-10 ug/mL Menadionerespiration

-0.162

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.588

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.223

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.806

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.675

NRP_1Non-replicating persistence stage 1dosRassociated

0.113

Amp0.2mg/mL AmpicillincellWall

0.161

Cephalexin20-100 ug/mL CephalexincellWall

0.374

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.149

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.139

EMB10-20 ug/mL EthambutolcellWall

0.446

Eta12-40 ug/mL EthionamidecellWall

1.002

INH0.2-0.4 ug/mL IsoniazidcellWall

0.250

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.849

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.901

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.569

BZA0.12 mg/mL BenzamidearomaticAmides

-0.419

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.417

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.484

H2O24 mM hydrogen peroxideDNAdamaging

0.906

Levo10 ug/mL LevofloxacinDNAdamaging

0.442

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.387

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.392

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.494

UVUV-irradiationDNAdamaging

0.114

ARP41-4 ug/mL Antitubercular compound ARP4?

0.086

Antimycin12.5-50 ug/mL Antimycin A?

0.509

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.280

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.131

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.892

PA8240.2-2 ug/mL PA-824?

0.261

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.405

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.204

Verapamil50 uM Verapamil?

-0.100

mercaptoethanol2 mM 2-Mercaptoethanol?

0.141

methoxatin10-20 ug/mL Methoxatin?